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The presence of hepatitis B virus DNA in the sera of individuals is the most definitive marker of an active
viral infection. We have used polymerase chain reaction detection of hepatitis B virus DNA directly on whole
blood dried as a spot on filter paper. The method is rapid, specific, and sensitive and has the ability to detect
as little as 10 virus particles by ethidium bromide staining of the polymerase chain reaction-amplified products.
The method is cost-effective, and the stability of the spots makes the collection and transportation of potentially
infectious blood safe.
Hepatitis B virus (HBV) infections represent a major
public health problem because of the ability ofHBV to cause
a chronic carrier state. Even though chronic carriers remain
largely asymptomatic, a large number of these individuals
subsequently develop cirrhosis and primary hepatocellular
carcinomas (2, 8). Active viral replication is traditionally
correlated with the serum markers hepatitis B e antigen
(HBeAg) and HBV-specific DNA polymerase or direct visu-
alization of virus in serum by electron microscopy (11).
These techniques, however, lack the sensitivity to detect
low levels of viremia. Nucleic acid hybridization and poly-
merase chain reaction (PCR) amplification methods have
been used for the detection of HBV in serum, with a
dramatic increase in sensitivity (5, 13, 16). These methods
suffer from the problem of being technically involved, re-
quiring the isolation of viral DNA before detection and the
preparation of probes, isotopic or otherwise. Our aim was to
develop a procedure that would be directly applicable to
blood without the need to separate serum or to isolate DNA.
Furthermore, we desired a procedure that could be per-
formed in a single reaction tube and would be free of
hybridization protocols that are time-consuming and require
the use of radioisotopes for maximum sensitivity.
The technique of collecting blood on filter paper aroused
our interest. Dried blood spots (4) are attractive, as they can
be prepared with a finger prick rather than with venipunc-
ture, thereby causing less discomfort to the donor. Further-
more, they require minimal storage space, pose little biohaz-
ard risk, and facilitate the shipment of specimens. Dried
blood spots have been widely used to screen for genetic and
metabolic disorders (9, 17, 18), to study polymorphisms in
parasitic diseases (12), and to evaluate specimens for infec-
tious diseases after shipment from areas of endemicity to a
central laboratory (3, 6). They are ideally suited for large-
scale population screening studies, whether for epidemiol-
ogy or blood bank procedures.
In this study, we have linked the dried blood spot collec-
tion method to PCR for the detection of HBV. The entire
procedure is carried out in a single reaction tube, is rapid,
and is specific. Agarose gel electrophoresis of PCR products
and ethidium bromide staining are capable of detecting as
few as 10 virus particles in the blood spot.
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MATERIALS AND METHODS
Sample collection. The samples used in this study had been
submitted for routine HBV serological testing and were part
of another study dealing with the transmission of HBV from
hepatitis B surface antigen (HBsAg)-positive mothers to
newborns. All sera were stored at -20°C. In the initial
experiments, stored sera were used after being mixed with
blood cells from a donor who was found negative for HBV
DNA by PCR amplification with at least two separate sets of
primers. Subsequently, whole blood from donors was col-
lected by finger pricking directly onto a piece of Whatman
3MM paper, and the paper was air dried and stored sealed in
a plastic bag at -20°C. Virus particles were purified by
sucrose density gradient ultracentrifugation (15) and quanti-
tated by dot blot hybridization with a 32P-labelled, full-length
HBV DNA probe (19). Standards containing known amounts
of cloned HBV DNA were run on the same blot for compar-
ison. The purified stock contained 106 virus particles per ,ul.
Sample preparation. For reconstitution, blood obtained by
finger pricking or venipuncture was diluted immediately into
10 volumes of ice-cold saline and the cells were pelleted at
4°C in a microcentrifuge (Eppendorf 5415) at 4,000 rpm for 2
min. After one wash with ice-cold saline, 0.7 volume of
serum (relative to the volume of blood originally used) was
added to the packed-cell pellet, and the reconstituted blood
was spotted immediately on precut 7-mm disks of Whatman
3MM filter paper or a nitrocellulose membrane (BA85;
Schleicher & Schuell). Disks were punched out of the dried
blood spots with a sterile punch. The disks were placed at
the bottom of 0.5-ml microcentrifuge tubes, 75 ,ul water was
added, and the tubes capped and subjected to radiation in a
microwave oven (Sharp carousel; 650 W) at full power for 10
min. After brief centrifugation in the microcentrifuge, the
PCR mixture was added.
The isolation of HBV DNA from serum was carried out by
a modification of a published procedure (1). To 25 ,lI of
serum was added 225 pul of a proteinase K solution contain-
ing 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 2.5 mM MgCl2,
0.1 mg of gelatin per ml, 0.45% Nonidet P-40, 0.45% Tween
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20, and 60 ,ug of proteinase K per ml (added fresh from a
10-mg/ml stock prepared in water). After incubation at 56°C
for 2 h, proteinase K was inactivated at 95°C for 10 min, and
50 ,ul of the mixture was used for PCR amplification.
HBV serological testing. The HBV carrier state of each
patient (donor) was determined by enzyme immunoassays
for HBsAg, HBeAg, and antibody to HBeAg (anti-HBe)
(Organon Teknika B.V., Boxtel, Holland) in accordance
with the manufacturer's instructions.
DNA amplification and detection. PCR amplifications were
carried out in a final volume of 100 ,ul containing 10 mM
Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl2, 0.01%
gelatin, 200 pRM each deoxynucleotide triphosphate, 50 pmol
each of the upstream and downstream primers, and 1.0 to 1.5
U of Taq polymerase (Stratagene, La Jolla, Calif.). After
layering with 100 RI of mineral oil (Sigma, St. Louis, Mo.),
amplifications were performed for the desired number of
cycles on an automated DNA thermocycler (Coy Corp., Ann
Arbor, Mich., or Cetus-Perkin Elmer, Norwalk, Conn.) in
accordance with the following cycling program: denaturation
at 94°C, annealing at 55°C, and extension at 72°C for 1 min
each, with a final extension at 72°C for 7 min.
The primer set used, 27-25, was previously used for
amplifying HBV DNA from sera and tissues (1, 16) and
amplified a conserved region of the core gene. The se-
quences of these primers are as follows: 27 (sense), 5'-GCG
GGATCCACTGTTCAAGCCTCCAAGCT-3', and 25 (anti-
sense), 5'-GCGAAGCTTAAGGAAAGAAGTCAGAAGG-
3'. Oligonucleotide primers were synthesized on an auto-
mated DNA synthesizer (model 380B; Applied Biosystems
Inc., Foster City, Calif.) by use of phosphoramidite chem-
istry. The crude oligonucleotides were precipitated with 2.2
M ammonium acetate and 2.5 volumes of ethanol prior to use
in the PCR.
Following amplifications, 10 ,u of the amplified mixture
was run on a 2% agarose (Bio-Rad, Richmond, Calif.) gel
and stained with ethidium bromide. For Southern blotting,
the stained gel was transferred to a nylon membrane (Zeta
probe; Bio-Rad) in transfer buffer, containing 10 mM NaOH
and 1 mM EDTA. Following overnight transfer, the mem-
brane was rinsed briefly in transfer buffer, and the DNA was
denatured with 0.4 M NaOH for 10 min. The membrane was
neutralized with 2x SSC (lx SSC is 0.15 M NaCl plus 0.015
M sodium citrate) and baked under vacuum at 80°C for 1 h.
Prehybridization, hybridization, and washes were performed
in accordance with published procedures (19). For hybrid-
ization, a 3.2-kb linearized fragment of cloned HBV DNA
was labelled with 32P by use of a nick translation kit (GIBCO
BRL, Gaithersburg, Md.). Slot blot hybridizations were
carried out as described elsewhere (19).
To avoid contamination and false-positivity in the PCR
results, we strictly applied published control measures (14).
To prevent cross-contamination at the blood spot level, we
applied the blood to precut circles of filter paper. When
blood spots were punched out, the stainless steel punch was
flamed with alcohol between samples. Spots were stored
sealed in separate, disposable plastic bags. Every PCR
amplification included positive and negative controls to
ascertain faithful amplification.
RESULTS
Initial investigations were aimed at evaluating whether the
PCR for HBV detection can be performed directly on whole
blood and whether the use of a solid support interferes with
such amplification. For this purpose, blood was obtained by
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FIG. 1. PCR amplifications of HBV DNA from dried spots of
blood from a positive donor (lanes 1, 3, and 5) and a negative donor
(lanes 2, 4, and 6). Lanes 1 and 2, spots applied to disks of Whatman
3MM filter paper; lanes 3 and 4, spots applied to disks of a BA85
nitrocellulose membrane; lanes 5 and 6, whole blood (without a solid
support); lane 7, cloned HBV DNA positive control; lane 8, MspI-
digested pBR322 DNA molecular weight markers. The sizes (base
pairs) of the relevant markers are indicated on the right. The
arrowhead on the left denotes the 140-bp amplified product.
finger pricking from one HBV-DNA positive donor and one
HBV DNA-negative donor. After spotting of 5 ,u of each
blood sample on Whatman 3MM filter paper or a BA85
nitrocellulose membrane, PCR amplifications were per-
formed directly with primers specific for the core region of
HBV. An amplified product of 140 bp was observed (Fig. 1).
That the amplified product was HBV specific was ascer-
tained by Southern blot hybridization with a cloned full-
length HBV probe (data not shown). The efficiency of the
PCR amplifications did not vary with the type of solid
support used (lanes 1 and 3) and appeared similar to that
obtained directly with whole blood (without a solid support)
(lane 5). For subsequent experiments, therefore, we used
filter paper as the support of choice.
Microwave treatment of HBV-positive sera has been
claimed to increase the sensitivity of detection (7). We
therefore used this method for our dried blood spot prepa-
rations. Microwave treatment prior to PCR amplifications
increased the signal by about two- to threefold, and it did not
matter whether the dried blood spots were subjected to
microwave treatment directly or after the addition of 75 Ru of
water to the tube (data not shown). Since elution from the
filter paper disk was more complete when microwaving was
done with liquid, water was added to the tube for all
subsequent investigations.
The sensitivity of the detection method was determined in
reconstitution experiments. Serial 10-fold dilutions of puri-
fied virus particles were prepared in blood from an HBV
DNA-negative donor, spotted on filter paper disks, and
analyzed by the PCR. Using this reconstitution system, we
were able to detect 104 virus particles in each 5-,u blood spot
after 40 cycles of amplification and ethidium bromide stain-
ing (Fig. 2A). This sensitivity was increased to 102 virus
particles in Southern blot or slot blot hybridization with a
32P-labelled HBV DNA probe (data not shown). A similar
sensitivity of 10 to 100 virus particles after ethidium bromide
staining was also obtained when the PCR amplification was
increased to 50 cycles (Fig. 2B). The sensitivity of ethidium
bromide stain-based detection can be increased another
three to four times by applying a larger sample size to the
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FIG. 2. PCR amplifications of HBV DNA from virus particle
dilutions, showing the sensitivity of the method. Purified virus
particles from a stock of 106 virus particles per p1l were diluted into
blood from an HBV DNA-negative donor, and 5 pAl was applied to
filter paper disks. Arrowheads indicate the amplified product. (A)
Results of amplifications carried out for 40 cycles. Lanes 1 through
7, decreasing numbers of virus particles (106, i05, 104, 103, 102, 10',
and 1, respectively); lane 8, molecular weight markers. (B) Results
of amplifications carried out for 50 cycles. Lanes 1 through 5,
decreasing numbers of virus particles (104, 103, 102, 10', and 1,
respectively); lane 6, reagent control; lane 7, cloned HBV DNA-
positive control; lane 8, molecular weight markers.
filter paper. In our experience, a 7-mm disk of Whatman
3MM filter paper can be saturated with about 20 pAl of blood.
The dried blood spot technique is ideally suited for the
collection of samples in the field and for safe transportation.
Therefore, we wanted to evaluate analyte stability in the
dried blood spots for PCR detection. Spots were stored at
370C for different times; complete stability was maintained
under these conditions for up to 5 months (Fig. 3). Gel
analysis of amplifications done on spots stored at 370C also
revealed fewer problems from interference due to denatured
proteins. Although there was no difference between DNA
amplifications (elutions) for spots stored at 37 versus -20'C,
significantly fewer denatured proteins were present in the
former after thermal cycling. It may therefore be helpful to
routinely store dried blood spots at room temperature prior
to analysis.
Finally, the suitability of this method of HBV DNA
detection was tested with spots of blood obtained from
mothers who were chronic HBV carriers (HBsAg positivity,
>6 months) and who were attending the maternity clinic of a
local hospital. A total of 60 such patients were analyzed for
their HBV DNA status either by PCR amplification of DNA
isolated from serum or by PCR amplification of dried blood
spots. The negative controls included five laboratory person-
nel who were healthy, asymptomatic individuals without any
previous episode of HBV infection and negative for HBsAg.
All five negative controls were found negative for HBV
DNA by the PCR.
Among the 60 HBsAg-positive carriers tested, three dis-
tinct subgroups emerged-HBeAg positive (m = 12), anti-
FIG. 3. Stability of the dried blood spots. Five microliters of
blood obtained by finger pricking from an HBV DNA-positive
patient was applied to each precut 7-mm filter paper disk and stored
at 37°C for various times. Amplifications were carried out for 50
cycles. Lanes 1 through 5, dried blood spots stored for 0, 1, 3, 5, and
7 days, respectively; lane 6, reagent control; lane 7, cloned HBV
DNA-positive control; lane 8, molecular weight markers; lanes 9
and 10, dried spots of blood obtained from a positive donor (lane 9)
or a negative donor (lane 10) and stored for 5 months. The
arrowhead indicates the amplified product.
HBe positive (m = 23), and HBeAg/ and anti-HBe negative
(m = 25). All 12 carriers who were found HBeAg positive
were also found HBV DNA positive by the conventional
serum DNA PCR as well as our technique. Among the
anti-HBe-positive carriers, 14 and 13 were found positive for
HBV DNA by the serum DNA PCR and our technique,
respectively; the remaining 8 carriers in this subgroup were
found negative for HBV DNA by both methods. Among the
HBeAg-negative and anti-HBe-negative carriers, 19 and 20
were found positive for HBV DNA by the serum DNA PCR
and our technique, respectively; 5 carriers were found
negative for HBV DNA by both methods. Of the 60 carriers
tested, 56 (43 positives and 13 negatives) matched perfectly
when analyzed by either method. Among the four carriers
that did not match, two were found positive by the serum
DNA PCR and negative by the blood spot PCR, whereas the
other two were found positive by the blood spot PCR and
negative by the serum DNA PCR. However, for all four
discrepant carriers, the amplified bands were very weak,
although reproducible. Thus, overall there was good agree-
ment between the conventional serum DNA PCR and our
blood spot PCR technique in assessing HBV DNA positivity
in chronic carriers.
DISCUSSION
We have developed a method for the detection of HBV
DNA directly in a dried blood spot by using PCR method-
ology. The procedure is sensitive, is specific, requires min-
imal sample handling, and is rapid, taking about 5 h from
start to finish.
The detection of HBV DNA is traditionally carried out by
dot blotting or PCR amplification of serum (7, 19) or DNA
isolated from serum (13, 20). Since all presently available
methods require serum as the starting material, blood must
be obtained by venipuncture. In this study, we have suc-
cessfully used PCR for HBV detection in dried spots of
blood collected by the finger prick method. The method is
capable of routinely detecting 10 to 100 virus particles
without the use of hybridization methods. In comparison,
direct dot blotting of serum coupled with hybridization to a
32P-labelled probe is capable of detecting as little as 0.1 to
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0.01 pg of HBV DNA, which corresponds to 104 to 103 virus
particles (19). The PCR was reported to be capable of
detecting 103 virus particles with ethidium bromide staining
and as few as 3 virus particles with Southern blotting (13).
Another report (20) claimed that the PCR with ethidium
bromide staining detected as few as 1 to 10 virus particles.
However, both of these reports are difficult to evaluate, as
cloned HBV DNA and not known amounts of virus were
used for the sensitivity analysis.
A potential problem with direct testing of blood by the
PCR is the presence of erythrocyte contaminants, particu-
larly the porphyrin moiety of heme, which is a strong
inhibitor of the PCR (10). Besides aiding in the disruption of
HBV particles, microwave treatment of sera prior to the
PCR was suggested to be capable of denaturing such inhib-
itory factors (7). Therefore, we introduced a microwave
treatment step to our protocol. The sensitivity of detection
of HBV in serum was estimated to be 10 virus particles with
the microwave treatment PCR method (7). Our lower limit of
sensitivity of 10 virus particles compares well with that in
this method, considering that significantly larger amounts of
potential erythrocyte contaminants are present in blood
spots than in serum.
Our quantitation experiments indicate that 10 virus parti-
cles can be detected after 50 amplification cycles. This
means that about 25 x 10-6 pg of HBV DNA (one virus
particle contains about 2.5 x 10-6 pg of DNA) can be
amplified 250 times, or about 10's times. After amplification
of 10 virus particles, 10% of the total material is barely
visible on an agarose gel. With a lower limit of detection of
10 to 20 ng, the final amplified mixture contains about 200 ng
of DNA. This corresponds to an amplification of about 1010
times. The average efficiency of each PCR cycle, therefore,
under the conditions of our assay is greater than 75%. The
limits of detection were found to be 104 and 10 particles after
40 and 50 amplification cycles, respectively. This 10-fold
increase in sensitivity agrees well with the relative increase
in theoretical product yield obtained with an increase from
40 to 50 amplification cycles.
When the blood spot PCR technique was used to assess
HBV DNA positivity in HBsAg-positive carriers, good
agreement was found with the established method of HBV
DNA detection by PCR following preparation of DNA from
serum. However, because the blood spot method is a single-
step procedure, it is more convenient and less prone to
contamination in a clinical laboratory setting. When this
technique was used to assess HBV DNA positivity in
HBeAg- or anti-HBe-positive carriers the data support pre-
vious observations (13, 20) that (i) HBV DNA positivity is
generally high in HBsAg- and HBeAg-positive sera, com-
pared with that in HBsAg- and anti-HBe-positive sera, and
(ii) seroconversion from HBeAg to anti-HBe may be accom-
panied by a decrease in, but not a total disappearance of,
circulating levels of virus particles.
Thus, we have developed a rapid, specific, and sensitive
direct test for HBV DNA in blood obtained from patients by
simple finger pricking. Whether such a method can be used
for the simultaneous detection of more than one blood-borne
pathogen remains to be seen and is the subject of current
investigations.
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